Primary Prevention of Concussion in Youth Ice Hockey Players

November 27, 2017 updated by: Sport Injury Prevention Research Centre
  1. Background and Rationale:

    Little is currently known about intrinsic risk factors for sport-related concussion in youth ice hockey players. Emerging research suggests that alterations in cervical and balance function increase the risk of concussion in youth ice hockey players. Thus, evaluation of a primary prevention program aimed at addressing alterations in cervical and vestibular function may result in a protective effect in reducing the risk of concussion. Such a program targeting intrinsic risk factors for concussion has not previously been evaluated and thus a pilot Randomized control trial (RCT) to inform the feasibility and efficacy of such a program is needed prior to proceeding to evaluation of such a program on a larger scale.

  2. Research Question and Objectives

    The primary objectives of this pilot RCT study are: 1) To evaluate the feasibility of a concussion prevention program in youth ice hockey players; and 2) To evaluate the efficacy of a concussion prevention program in decreasing the risk of concussion. Exploratory objectives include evaluating the changes in quality of life, clinical measures of cervical and vestibular function measures and Hockey Canada on-ice skills testing in youth ice hockey players following a concussion prevention program.

  3. Methods

This study will be a pilot RCT. Prior to the 2017 hockey season, 120 players from 8 youth ice hockey teams ages 13-17 will be recruited to participate. Once parental consent and/or player assent has been obtained, players will complete a series of initial intake forms. Baseline tests and measures, including a standardized preseason baseline questionnaire (regarding playing history, past medical history, participation in sport) and a battery of questionnaires and clinical measures. Individuals will be randomly allocated into either a control protocol (general cardiovascular warm-up, general stretching and strengthening, education on concussion identification) or a specific protocol (balance, neuromotor control, strength, vestibulo-ocular and oculomotor training + concussion education). Both groups will meet with the study physiotherapist once weekly for 4 weeks and exercises will be progressed. A previously validated prospective injury surveillance system will be implemented. As part of this process, a team designate will collect data throughout the season regarding individual player participation in games, practices and dry land training sessions. Individuals with a suspected concussion will be referred to the study sport medicine physician for evaluation, diagnosis and standard of care management. At this time all baseline tests and measures will be repeated.

Study Overview

Status

Unknown

Conditions

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T2N 1N4
        • Recruiting
        • University of Calgary Sport
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Inclusion criteria will broadly include individuals aged 13 - 17 years of age who are currently participating in organized ice hockey.

Exclusion Criteria:

  • Inability to participate in physical activity for a reason other than sport related concussion.
  • Inability to communicate in English language.
  • Neurodevelopmental delays expected to affect ability to adapt with treatment.
  • Orthopaedic or other injury affecting ability to participate.
  • Medication known to affect neural adaptation as they may alter the response to treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Specific Protocol
The intervention group will work with the study physiotherapist and perform a 10-20 minute progressive exercises twice per week. The intervention will include a series of exercises including dynamic balance, adaptation, cervical spine strength, cervical spine neuromotor control and divided attention exercises. Exercises will begin at a lower level and progress to increasingly difficult levels of each exercise type over the course of the intervention. Concussion education and injury identification will also be completed.
Series of progressive exercises targeted at balance, adaptation, dividing attention, head on neck control, visual + education on concussion identification and concussion education
Active Comparator: Control Protocol
The control group will continue with their standard warm up and practice schedule but have the addition of contact time with the study physiotherapist for education regarding concussion education and injury identification.
Education on concussion and concussion identification in addition to typical cardiovascular warmups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy of Concussion prevention protocol
Time Frame: 6 months (length of hockey season)
A primary outcome of interest is diagnosis of concussion. This will be determined by the study sport medicine physician in accordance with current standards of care and as per the 5th International Consensus on Concussion in Sport Statement. Medical clearance to return to sport will be determined by the study sport medicine physician according to the 5th Consensus on Concussion in Sport Statement.
6 months (length of hockey season)
Number of participants able to complete protocol.
Time Frame: 6 months (length of hockey season)
Number of participants completing each intervention will be calculated
6 months (length of hockey season)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pediatric Quality of Life Scale (PedsQL)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
The Pediatric Quality of Life Scale (PedsQL) is a measure of quality of life that is specific to children and measures four health domains including: Physical, emotional, social and school functioning. It is a measure that has demonstrated reliability and validity in multiple disease types in children, including traumatic brain injury. 0-100/100
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Numeric Pain Rating Scale for Neck pain
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Neck pain rated from 0-10/10
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Numeric Pain Rating Scale for Headache
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Headache pain rated from 0-10/10
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Numeric Dizziness Rating Scale
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Dizziness rated from 0-10/10
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Sport Concussion Assessment Tool 5 (SCAT5)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Multifaceted assessment tool including symptom reports (rated 0-6 for 22 different symptoms), Cognitive Screen (score /30), Neurological screen (Y/N for 5 questions and balance exam /30)
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Dynamic Visual Acuity (DVA)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Clinical test of dynamic visual acuity using ETDRS chart
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Head Thrust Test (HTT)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Clinical test to evaluate ability to maintain eyes on a stationary target. Performed to right and left. (+ve/-ve)
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Functional Gait Assessment (FGA)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Dynamic balance measure including 10 different walking tasks that are rated on a scale of 0-3 for a total score out of 30
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Advanced Functional Gait Assessment (A-FGA)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Newly created balance measure that represents a more difficult measure of dynamic balance and is a combination of progressively more difficult tasks included in the FGA. Clinician rated score 0-3 for each task. Total score out of 18
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Walking While Talking Test (WWTT)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Test of walking and performing cognitive tasks of increasing difficulty, Time (seconds) for each task is recorded.
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Cervical Flexion Endurance test (CFE)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Test performed in crook lying that measures the ability of a subject to maintain head in a craniovertebral flexion position and slightly lifted off pillow. Time (seconds)
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Cervical Flexion Rotation Test (CFRT)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Screening test for upper cervical spine involvement. Positive/negative and is performed to both right and left.
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Anterolateral cervical spine strength
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Measured using a head held dynamometer with subject in supine position. Test is repeated 3 times. Output measured in kg.
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Head perturbation test (HPT)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
Ability to maintain head in a neutral position with external perturbation applied. Score out of 8 is recorded
Time 0, 4 weeks, end of hockey season (approximately 6 months)
Vestibular/Ocular Motor Screening Assessment (VOMS)
Time Frame: Time 0, 4 weeks, end of hockey season (approximately 6 months)
As per Mucha et al, 2014
Time 0, 4 weeks, end of hockey season (approximately 6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kathryn J Schneider, PT, PhD, Sport Injury Prevention Research Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 4, 2017

Primary Completion (Anticipated)

August 31, 2018

Study Completion (Anticipated)

December 29, 2018

Study Registration Dates

First Submitted

October 24, 2017

First Submitted That Met QC Criteria

November 27, 2017

First Posted (Actual)

December 4, 2017

Study Record Updates

Last Update Posted (Actual)

December 4, 2017

Last Update Submitted That Met QC Criteria

November 27, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • Conc-PT-03

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

At this time there is no plan to share individual participant data with others outside of the research team.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Concussion

Clinical Trials on Specific intervention

Subscribe